CRBU
Price
$5.71
Change
-$0.10 (-1.72%)
Updated
Dec 5, 6:59 PM EST
104 days until earnings call
MDGL
Price
$235.11
Change
+$13.13 (+5.91%)
Updated
Dec 5, 6:59 PM EST
79 days until earnings call
Ad is loading...

Compare trend and price CRBU vs MDGL

Header iconCRBU vs MDGL Comparison
Open Charts CRBU vs MDGLBanner chart's image
Caribou Biosciences
Price$5.71
Change-$0.10 (-1.72%)
Volume$585.93K
CapitalizationN/A
Madrigal Pharmaceuticals
Price$235.11
Change+$13.13 (+5.91%)
Volume$204.28K
CapitalizationN/A
View a ticker or compare two or three
CRBU vs MDGL Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CRBU vs. MDGL commentary
Dec 06, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a StrongSell and MDGL is a Buy.

COMPARISON
Comparison
Dec 06, 2023
Stock price -- (CRBU: $5.71 vs. MDGL: $235.11)
Brand notoriety: CRBU and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 42% vs. MDGL: 49%
Market capitalization -- CRBU: $508.48M vs. MDGL: $3.9B
CRBU [@Biotechnology] is valued at $508.48M. MDGL’s [@Biotechnology] market capitalization is $3.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than MDGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 6 TA indicator(s) are bullish while MDGL’s TA Score has 6 bullish TA indicator(s).

  • CRBU’s TA Score: 6 bullish, 4 bearish.
  • MDGL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CRBU and MDGL are a good buy in the short-term.

Price Growth

CRBU (@Biotechnology) experienced а -2.06% price change this week, while MDGL (@Biotechnology) price change was +23.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.01%. For the same industry, the average monthly price growth was +25.34%, and the average quarterly price growth was +25.64%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 18, 2024.

MDGL is expected to report earnings on Feb 22, 2024.

Industries' Descriptions

@Biotechnology (+11.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CRBU with price predictions.
OPEN
A.I.dvisor published
a Summary for MDGL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MDGL($3.9B) has a higher market cap than CRBU($508M). CRBU YTD gains are higher at: -9.076 vs. MDGL (-18.997). CRBU has higher annual earnings (EBITDA): -105.9M vs. MDGL (-336.4M). CRBU has more cash in the bank: 338M vs. MDGL (232M). CRBU has less debt than MDGL: CRBU (27.5M) vs MDGL (117M). CRBU has higher revenues than MDGL: CRBU (34.6M) vs MDGL (0).
CRBUMDGLCRBU / MDGL
Capitalization508M3.9B13%
EBITDA-105.9M-336.4M31%
Gain YTD-9.076-18.99748%
P/E RatioN/AN/A-
Revenue34.6M0-
Total Cash338M232M146%
Total Debt27.5M117M24%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUMDGL
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 6 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 27 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BITC37.011.60
+4.52%
Bitwise Bitcoin Strategy Optm Roll ETF
IBMO25.380.05
+0.20%
iShares iBonds Dec 2026 Term Muni Bd ETF
SIFI42.950.06
+0.14%
Harbor Scientific Alpha Income ETF
GDL7.94-0.01
-0.13%
GDL Fund (The)
FAS72.27-0.98
-1.34%
Direxion Daily Financial Bull 3X ETF

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with VKTX. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
+5.91%
VKTX - MDGL
63%
Loosely correlated
+15.12%
SGMO - MDGL
62%
Loosely correlated
-7.96%
IBRX - MDGL
62%
Loosely correlated
-1.08%
KA - MDGL
62%
Loosely correlated
-3.24%
RVMD - MDGL
61%
Loosely correlated
-2.93%
More